These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 20515289)
21. A comparison of ultrasound measurements to assess carotid atherosclerosis development in subjects with and without type 2 diabetes. Pollex RL; Spence JD; House AA; Fenster A; Hanley AJ; Zinman B; Harris SB; Hegele RA Cardiovasc Ultrasound; 2005 Jun; 3():15. PubMed ID: 15958169 [TBL] [Abstract][Full Text] [Related]
22. Coronary artery calcium outperforms carotid artery intima-media thickness as a noninvasive index of prevalent coronary artery stenosis. Terry JG; Carr JJ; Tang R; Evans GW; Kouba EO; Shi R; Cook DR; Vieira JL; Espeland MA; Mercuri MF; Crouse JR Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1723-8. PubMed ID: 15947237 [TBL] [Abstract][Full Text] [Related]
23. Serum dehydroepiandrosterone sulfate concentration and carotid atherosclerosis in men with type 2 diabetes. Fukui M; Kitagawa Y; Nakamura N; Kadono M; Yoshida M; Hirata C; Wada K; Hasegawa G; Yoshikawa T Atherosclerosis; 2005 Aug; 181(2):339-44. PubMed ID: 16039288 [TBL] [Abstract][Full Text] [Related]
24. Progression of calcified coronary atherosclerosis: relationship to coronary risk factors and carotid intima-media thickness. Taylor AJ; Bindeman J; Le TP; Bauer K; Byrd C; Feuerstein IM; Wu H; O'Malley PG Atherosclerosis; 2008 Mar; 197(1):339-45. PubMed ID: 17727858 [TBL] [Abstract][Full Text] [Related]
25. Family history of coronary heart disease and markers of subclinical cardiovascular disease: where do we stand? Pandey AK; Pandey S; Blaha MJ; Agatston A; Feldman T; Ozner M; Santos RD; Budoff MJ; Blumenthal RS; Nasir K Atherosclerosis; 2013 Jun; 228(2):285-94. PubMed ID: 23578356 [TBL] [Abstract][Full Text] [Related]
31. Assessment of subclinical atherosclerosis and cardiovascular risk. Benitez RM; Vogel RA Clin Cardiol; 2001 Oct; 24(10):642-50. PubMed ID: 11594409 [TBL] [Abstract][Full Text] [Related]
32. Serum bilirubin and genes controlling bilirubin concentrations as biomarkers for cardiovascular disease. Lin JP; Vitek L; Schwertner HA Clin Chem; 2010 Oct; 56(10):1535-43. PubMed ID: 20693308 [TBL] [Abstract][Full Text] [Related]
33. [Biomarkers in primary cardiovascular prevention: rationale, premises, and promises]. Muscente F; De Caterina R G Ital Cardiol (Rome); 2017 Feb; 18(2):106-120. PubMed ID: 28398364 [TBL] [Abstract][Full Text] [Related]
34. Circulating cells as predictors of secondary manifestations of cardiovascular disease: design of the CIRCULATING CELLS study. Hoefer IE; Sels JW; Jukema JW; Bergheanu S; Biessen E; McClellan E; Daemen M; Doevendans P; de Groot P; Hillaert M; Horsman S; Ilhan M; Kuiper J; Pijls N; Redekop K; van der Spek P; Stubbs A; van de Veer E; Waltenberger J; van Zonneveld AJ; Pasterkamp G Clin Res Cardiol; 2013 Nov; 102(11):847-56. PubMed ID: 23975238 [TBL] [Abstract][Full Text] [Related]